Yuki Gosei Kogyo
4531.TTSE STANDARDPharmaceutical
Filed as Yuki Gosei Kogyo Co., Ltd. (2022-06–2026-06)
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥15.4bn | ¥15.1bn | ¥12.9bn | ¥12.8bn | ¥12.4bn | ¥11.1bn |
| Operating income | ¥383m | ¥1.2bn | ¥1.1bn | ¥897m | ¥413m | ¥218m |
| Ordinary income | ¥303m | ¥1.1bn | ¥1.1bn | ¥660m | ¥397m | ¥176m |
| Total assets | ¥25.7bn | ¥26.9bn | ¥24.4bn | ¥22.1bn | ¥21.2bn | ¥21.0bn |
| Net assets / equity | ¥13.5bn | ¥13.1bn | ¥12.4bn | ¥11.5bn | ¥11.0bn | ¥10.9bn |
| Operating cash flow | ¥2.8bn | ¥2.1bn | ¥388m | ¥668m | ¥1.8bn | ¥352m |
| EPS (basic) | ¥14.51 | ¥41.4 | ¥35.57 | ¥25.51 | ¥11.37 | ¥13.22 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 118 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 118 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 118 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 118 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 118 figures · EDINET |
23 more reports are still being processed.